Abstract
Approximately 50% of patients recovering from acute myocardial infarction have significant left ventricular systolic dysfunction and could benefit considerably from the long-term administration of angiotensin-converting enzyme inhibitors. This article summarizes the evidence for the use of these drugs and addresses the practical issues involved in their administration.
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Aspirin / therapeutic use
-
Clinical Trials as Topic
-
Drug Therapy, Combination
-
Female
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Male
-
Myocardial Infarction / drug therapy*
-
Patient Selection
-
Ventricular Dysfunction, Left / drug therapy
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Fibrinolytic Agents
-
Aspirin